Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Amortizatization of Intangibles of $562000.0 for Q1 2026, down 57.62% year-over-year from $1.3 million in Q1 2025, and up 27.73% quarter-over-quarter from $440000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 5 years of Amortizatization of Intangibles data on file, last reported at $562000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $562000.0, down 57.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (down 68.07% YoY), and the FY2025 annual result was $3.7 million, down 60.11% from the prior year.
- Amortizatization of Intangibles rose to $562000.0 in Q1 2026 per LXRX's latest filing, from $440000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $3.3 million in Q2 2024 and troughed at $440000.0 in Q4 2025.
- A 4-year average of $1.6 million and a median of $1.4 million in 2024 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 5.22% in 2025 and fell as far as 76.68% in 2025.
- A 4-year view of Amortizatization of Intangibles shows it stood at $2.0 million in 2023, then dropped by 5.84% to $1.9 million in 2024, then plunged by 76.68% to $440000.0 in 2025, then gained by 27.73% to $562000.0 in 2026.
- Business Quant data shows LXRX's Amortizatization of Intangibles at $562000.0 in Q1 2026, $440000.0 in Q4 2025, and $732000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |